Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 5, 2012, Pages 422-433

  Weinger, Jason G ^a   Davies, Peter ^a,b   Acker, Christopher M ^a   Brosnan, Celia F ^a   Tsiperson, Vladislav ^a   Bayewitz, Ashrei ^a   Shafit Zagardo, Bridget ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Institute of Medical Research   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Axonal damage; Experimental autoimmune encephalomyelitis; Growth arrestYspecific protein 7b; Microtubuleassociated protein 1b; Multiple sclerosis; Myelin oligodendrocyte glycoprotein (MOG); Tau

Indexed keywords

BINDING PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 7B; MICROTUBULE ASSOCIATED PROTEIN 5; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; GRAY MATTER; IMMUNOBLOTTING; MALE; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SENSITIZATION; SPINAL CORD; WHITE MATTER; WILD TYPE;

AGE FACTORS; ANIMALS; AXONS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; NEURONS; PARALYSIS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SPINAL CORD; TAU PROTEINS;

EID: 84860218100     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182540d2e     Document Type: Article

References (46)

1. Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta 2011;1812:252-64
2. Barnett MH, Parratt JD, Pollard JD, et al. MS: Is it one disease? Int MS J 2009;16:57-65
3. Frohman EM, Racke MK, Raine CS. Multiple sclerosisVThe plaque and its pathogenesis. N Engl J Med 2006;354:942-55
4. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;118:1583-92 (Pubitemid 26011926)
5. De Stefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;21: 1469-77 (Pubitemid 28349900)
6. Kornek B, Lassmann H. Axonal pathology in multiple sclerosis. A historical note. Brain Pathol 1999;9:651-56 (Pubitemid 29470958)
7. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-99 (Pubitemid 27153632)
8. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85 (Pubitemid 28065253)
9. Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000;123:1174-83 (Pubitemid 30312109)
10. Compston A. Making progress on the natural history of multiple sclerosis. Brain 2006;129:561-63 (Pubitemid 43278219)
11. O'Neill JK, Baker D, Morris MM, et al. Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease. J Neuroimmunol 1998;82:210-18 (Pubitemid 28179924)
12. Aboul-Enein F, Weiser P, Hoftberger R, et al. Transient axonal injury in the absence of demyelination: A correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol 2006; 111:539-47 (Pubitemid 43778958)
13. Shriver LP, Dittel BN. T cellYmediated disruption of the neuronal microtubule network: Correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. Am J Pathol 2006;169:999-1011 (Pubitemid 44411962)
14. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993;16:460-65 (Pubitemid 23313524)
15. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422:688-94 (Pubitemid 36514101)
16. Kempf M, Clement A, Faissner A, et al. Tau binds to the distal axon early in development of polarity in a microtubule-and microfilamentdependent manner. J Neurosci 1996;16:5583-92 (Pubitemid 26293382)
17. Magnani E, Fan J, Gasparini L, et al. Interaction of tau protein with the dynactin complex. EMBO J 2007;26:4546-54 (Pubitemid 350036634)
18. Sontag E, Nunbhakdi-Craig V, Lee G, et al. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 1996;17:1201-7 (Pubitemid 27021104)
19. Lee G, Newman ST, Gard DL, et al. Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 1998;111:3167-77 (Pubitemid 28532427)
20. Lu PJ, Wulf G, Zhou XZ, et al. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999;399:784-88 (Pubitemid 29293174)
21. Lim J, Lu KP. Pinning down phosphorylated tau and tauopathies. Biochim Biophys Acta 2005;1739:311-22 (Pubitemid 40018547)
22. Liou YC, Sun A, Ryo A, et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003;424: 556-61 (Pubitemid 36975777)
23. Borysov SI, Schmid AB, Abisambra JF, et al. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci 2010;30:591-9
24. Chambraud B, Sardin E, Giustiniani J, et al. A role for FKBP52 in Tau protein function. Proc Natl Acad Sci USA 2010;107:2658-63
25. Akiyama H, Gotoh A, Shin RW, et al. A novel role for hGas7b in microtubular maintenance: Possible implication in tau-associated pathology in Alzheimer disease. J Biol Chem 2009;284:32695-99
26. Schlatterer SD, Tremblay MA, Acker CM et al. c-Abl in neurodegenerative disease. J Mol Neurosci 2011;25:119-33
27. Schneider A, Araújo GW, Trajkovic K, et al. Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis. J Biol Chem 2004;279:55833-39 (Pubitemid 40066591)
28. Anderson JM, Hampton JM, Patani R, et al. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain 2008;131: 1736-48 (Pubitemid 351957465)
29. Anderson JM, Patani R, Reynolds R, et al. Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis. Acta Neuropathol 2009;117:583-89
30. Tucker KL, Meyer M, Barde YA. Neurotrophins are required for nerve growth during development. Nat Neurosci 2001;4:29-37
31. Andorfer C, Kress Y, Espinoza M, et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 2003;86:582-90 (Pubitemid 36897439)
32. Duff K, Knight H, Refolo LM, et al. Characterization of pathology in transgenic mice overexpressing human genomic and cDNA tau transgenes. Neurobiol Dis 2000;7:87-98 (Pubitemid 30241205)
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
34. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-54 (Pubitemid 9256559)
35. Boyne LJ, Tessler A, Murray M, et al. Distribution of Big tau in the central nervous system of the adult and developing rat. J Comp Neurol 1995;358:279-93
36. Roberson ED, Scearce-Levie K, Palop JJ, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007;316:750-54 (Pubitemid 46717684)
37. Sharma VM, Litersky JM, Bhaskar K, et al. Tau impacts on growth factorYstimulated actin remodeling. J Cell Sci 2007;120:748-57 (Pubitemid 46523477)
38. Leugers CJ, Lee G. Tau potentiates nerve growth factor-induced mitogenactivated protein kinase signaling and neurite initiation without a requirement for microtubule binding. J Biol Chem 2010;285:19125-34
39. Brandt R, Léger J, Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 1995;131:1327-40
40. Hantman AW, van den Pol AN, Perl ER. Morphological and physiological features of a set of spinal substantia gelatinosa neurons defined by green fluorescent protein expression. J Neurosci 2004;24:836-42 (Pubitemid 38146594)
41. Tucker RP, Matus A. Microtubule-associated proteins characteristic of embryonic brain are found in the adult mammalian retina. Dev Biol 1998;130:423-34
42. Tucker RP. The roles of MAPs in brain morphognesis: A review. Brain Res Brain Res Rev 1990;15:101-20
43. Tint I, Fischer I, Black M. Acute inactivation of MAP1b in growing sympathetic neurons destabilizes axonal microtubules. Cell Motil Cytoskeleton 2005;60:48-65 (Pubitemid 40066226)
44. Vouyiouklis DA, Brophy PJ. MAP-1b expression precedes the morphological differentiation of oligodendrocytes. J Neurosci Res 1993;35: 257-67 (Pubitemid 23182725)
45. Uchida T, Akiyama H, Sakamoto W, et al. Direct optical microscopic observation of the microtubule polymerization intermediate sheet structure in the presence of gas7. J Mol Biol 2009;391:849-57
46. You JJ, Lin-Chao S. Gas7 functions with N-WASP to regulate the enurite outgrowth of hippocampal neurons. J Biol Chem 2010;285: 11652-66